![Craig Parker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Craig Parker
Directeur Général chez
SURROZEN, INC.
Fortune : 584 872 $ au 30/09/2026
Profil
Mr. Craig C.
Parker is a Venture Partner at The Column Group LLC, a President, Chief Executive Officer & Director at Surrozen Operating, Inc., a President, Chief Executive Officer & Director at Surrozen, Inc. and a Chairman-Leadership Council at University of Michigan.
He is on the Board of Directors at Surrozen Operating, Inc. and Surrozen, Inc.
Mr. Parker was previously employed as an Independent Director by vTv Therapeutics, Inc., a Senior VP-Corporate Development by Jazz Pharmaceuticals Plc, an EVP-Corporate Development & Scientific Affairs by Geron Corp., a Senior VP-Strategy & Corporate Development by Human Genome Sciences, Inc., a Chief Executive Officer by Vega Therapeutics, Inc., a Senior Vice President & General Manager by Immunex Corp., a Managing Director by Lehman Brothers, Inc., and a Chief Financial Officer by Proteolix, Inc. He also served on the board at Gryphon Therapeutics, Inc.
He received his undergraduate degree from The University of Chicago, an MBA from the University of Michigan, an MBA from Stephen M.
Ross School of Business and a doctorate degree from Georgetown University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SURROZEN INC 0,15 % | 15/06/2026 | 18 175 ( 0,15 % ) | 584 872 $ | 30/09/2026 |
Postes actifs de Craig Parker
| Sociétés | Poste | Début |
|---|---|---|
| SURROZEN, INC. | Directeur Général | 01/03/2018 |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Private Equity Investor | 01/06/2024 |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Président | - |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Directeur Général | 04/04/2018 |
Anciens postes connus de Craig Parker
| Sociétés | Poste | Fin |
|---|---|---|
| VTV THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/02/2019 |
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/03/2018 |
| GERON CORPORATION | Directeur Technique/Scientifique/R&D | 31/07/2014 |
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical related products | Directeur Financier/CFO | 26/11/2013 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Corporate Officer/Principal | 03/08/2012 |
Formation de Craig Parker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Manufactures, markets, and researches therapeutic products | Health Technology |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Gryphon Therapeutics, Inc.
 Gryphon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces protein therapeutics | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical related products | Health Technology |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Stephen M. Ross School of Business
 Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Vega Therapeutics, Inc.
 Vega Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engagers in R&D and manufactures antibodies that targets proteins | Health Technology |
Georgetown University School of Medicine
 Georgetown University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
vTv Therapeutics, Inc.
 vTv Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company which engages in discovery and development of orally administered small molecule drugs for treating metabolic and inflammatory disorders | Health Technology |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Health Technology |
Surrozen, Inc.
 Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
